Molecular diagnostics solutions at Medic Can Tho Hospital
The Mekong Delta is one of the regions with limited opportunities for quick access to high-quality healthcare services. Critically ill patients whose conditions exceed local diagnostic and treatment capabilities often have to travel for several hours to reach higher-level hospitals with in-depth specialties for examination and treatment. Understanding the healthcare needs of people in the Mekong Delta, medical staff and doctors with many years of dedication to the profession, great passion and experience cherished the dream and ambition of bringing to Can Tho, a major urban center in the Mekong Delta, high-quality, comprehensive and standardized healthcare services on par with major hospitals and medical centers nationwide. The goal was to give local people the fastest possible access to high-tech, high-quality healthcare services, shortening time and saving treatment costs. From that ambition and dream, on Sep 8, 2016, the first brick was laid for Hoa Hao - Medic Can Tho General Hospital.
The hospital's strengths lie in diagnostic imaging and laboratory testing, backed by modern machinery and medical equipment, an experienced and highly qualified team of doctors and medical staff, spacious and modern examination and treatment facilities, and attentive healthcare services.
Hoa Hao - Medic Can Tho General Hospital strives to become a strong, professionally operated medical facility in Can Tho and the Mekong Delta, aiming to be a top-tier medical center in Vietnam. Its vision: "To build and develop the hospital into a trusted healthcare provider, leading in service quality and the application of science and technology, meeting the needs for comprehensive examination, treatment and healthcare of people in the Mekong Delta provinces".
Viet Huy technicians providing technology transfer
The molecular diagnostics laboratory is equipped with molecular biology instruments for diagnosis/testing
Source: Hoa Hao - Medic Can Tho General Hospital
Related Articles

FDA Approves Zidesamtinib (Jideytro) for ROS1+ Lung Cancer
The FDA has officially approved Zidesamtinib (Jideytro) for patients with ROS1+ non-small cell lung cancer previously treated with a TKI. Learn about its clinical efficacy now.
Read moreVIET HUY NEW YEAR KICKOFF 2026: RECHARGED AND READY FOR A BREAKTHROUGH 2026
Summary of the 2026 New Year kickoff article by VIET HUY Technological Scientific Equipment Co., Ltd: Event: The Viet Huy team officially returned to work after the Tet holiday with traditional activities such as exchanging New Year wishes, handshakes, and giving lucky red envelopes. Goals for 2026: Improve the quality of services and technical solutions. Accelerate innovation and creativity in scientific & biomedical equipment. Increase sustainable value for partners and customers. Message: A spirit of unity, a determination to break through, and a drive for success in the new year's projects. Contact information: Head office in Ho Chi Minh City, representative offices in Hanoi and Da Nang, and Hotline: 0913 605 512.
Read more
CERVICAL CANCER SCREENING - THE ROLE OF HPV TESTING
Cervical cancer is a dangerous and common disease in women. However, it can be effectively prevented through screening and HPV vaccination
Read moreNeed help choosing the right testing solution?
Viet Huy engineers are ready to help your laboratory choose the optimal technology.